Respiratory Trials·org

Sepsis & septic shock · Protocolised early resuscitation

ARISE randomised trial

Goal-directed resuscitation for patients with early septic shock

ARISE trial design and results
Design Multicentre randomised controlled trial
Treatment Early goal-directed therapy
Control Usual care
Population 1600 patients presenting to the emergency department with early septic shock
Follow-up 90 days
Primary endpoint All-cause mortality at 90 days
Result 796 patients were assigned to early goal-directed therapy and 804 to usual care, with primary outcome data available for over 99%. The EGDT group received a larger mean volume of intravenous fluid and more vasopressors and transfusions, without any reduction in 90-day mortality.
Secondary endpoints Organ support, length of stay, quality of life

In critically ill patients presenting to the emergency department with early septic shock, EGDT did not reduce all-cause mortality at 90 days.

The trial authors, in the published abstract

How it has aged

The second replication failure, in Australasia. Together with ProCESS and ProMISe it produced an unusually clean verdict on a practice that had already been embedded in international guidelines and quality metrics.

Publications

Goal-directed resuscitation for patients with early septic shock

Peake SL, Delaney A, Bailey M, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014 Oct 16;371(16):1496-506.

  • No reduction in 90-day all-cause mortality
  • More fluid, vasopressors and transfusion in the EGDT arm